Two Sigma Investments’s Aligos Therapeutics ALGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$87K Buy
12,073
+1,023
+9% +$7.38K ﹤0.01% 2964
2025
Q1
$91.2K Buy
+11,050
New +$91.2K ﹤0.01% 2911
2024
Q3
Sell
-748
Closed -$6.55K 3030
2024
Q2
$6.55K Buy
748
+3
+0.4% +$26 ﹤0.01% 2890
2024
Q1
$18.3K Hold
745
﹤0.01% 2857
2023
Q4
$12.4K Sell
745
-172
-19% -$2.86K ﹤0.01% 2986
2023
Q3
$17.1K Sell
917
-250
-21% -$4.67K ﹤0.01% 2798
2023
Q2
$28.3K Sell
1,167
-1,107
-49% -$26.9K ﹤0.01% 2803
2023
Q1
$49.7K Sell
2,274
-1,343
-37% -$29.3K ﹤0.01% 2679
2022
Q4
$86.2K Sell
3,617
-1,360
-27% -$32.4K ﹤0.01% 2467
2022
Q3
$137K Sell
4,977
-2,839
-36% -$78.1K ﹤0.01% 2139
2022
Q2
$236K Sell
7,816
-292
-4% -$8.82K ﹤0.01% 2044
2022
Q1
$436K Buy
8,108
+5,413
+201% +$291K ﹤0.01% 2046
2021
Q4
$800K Sell
2,695
-900
-25% -$267K ﹤0.01% 1759
2021
Q3
$1.39M Buy
+3,595
New +$1.39M ﹤0.01% 1539